{"schema_version":"secwatch.filing_event.v1","accession":"0001551152-26-000023","form_type":"8-K","ticker":"ABBV","cik":"0001551152","company_name":"AbbVie Inc.","filed_at":"2026-07-31T11:51:32+00:00","discovered_at":"2026-07-31T11:55:00.368784+00:00","generated_at":"2026-07-31T11:55:07.911981+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"AbbVie Q2 2026: adj. EPS $3.65 (+22.9% YoY), revenue $16.99B (+10.2%); announces $10.9B Apogee acquisition","bullets":["GAAP diluted EPS $2.03 (+290.4% YoY); adjusted diluted EPS $3.65 (+22.9% YoY); includes $0.17 IPR&D impact.","Net revenues $16.99B (+10.2% reported, +9.5% operational); Immunology $8.786B (+15.1%) led by Skyrizi $5.505B (+24.4%).","Neuroscience $3.228B (+20.3%); Oncology $1.650B (-1.5%); Aesthetics $1.282B (+0.3%).","Announces definitive agreement to acquire Apogee Therapeutics for ~$10.9B equity value; expected close Q3 2026.","Updates 2026 adj. EPS guidance to $13.87-$14.07 (from $13.91-$14.11); includes $0.14 dilutive impact from Apogee."],"urls":{"canonical":"https://secwatch.observer/filing/0001551152-26-000023","json":"https://secwatch.observer/filing/0001551152-26-000023.json","markdown":"https://secwatch.observer/filing/0001551152-26-000023.md","text":"https://secwatch.observer/filing/0001551152-26-000023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1551152/000155115226000023/0001551152-26-000023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1551152/000155115226000023/abbv-20260731.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-31T11:55:07.911981+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}